- Conditions
- Rheumatoid Arthritis
- Interventions
- Upadacitinib, Adalimumab, Upadacitinib Matching Placebo, Adalimumab Matching Placebo
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 487 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 85
- States / cities
- Flagstaff, Arizona • Glendale, Arizona • Peoria, Arizona + 75 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 2209–2232
of 4,176
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Plague, Pneumonic, Plague, Vaccine-Preventable Diseases
- Interventions
- rF1V-1018, rF1V vaccine
- Biological
- Lead sponsor
- Dynavax Technologies Corporation
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2024
- U.S. locations
- 6
- States / cities
- Huntsville, Alabama • San Diego, California • Melbourne, Florida + 3 more
- Conditions
- Health Knowledge, Attitudes, Practice, Training
- Interventions
- Comprehensive sexual health curriculum
- Behavioral
- Lead sponsor
- University of Minnesota
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 412 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Minneapolis, Minnesota
- Conditions
- Muscle Damage
- Interventions
- cold water immersion, beta-hydroxy-beta-methylbutyrate free acid (HMB-FA), Placebo
- Procedure · Dietary Supplement
- Lead sponsor
- Metabolic Technologies Inc.
- Industry
- Eligibility
- 18 Years to 35 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Orlando, Florida
- Conditions
- Laryngeal Masks in Children
- Interventions
- LMA Supreme: control device, i-gel: comparison device
- Device
- Lead sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Other
- Eligibility
- 3 Months to 11 Years
- Enrollment
- 170 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Mucosal Erosion, Gingival Recession
- Interventions
- Visual Analog scale (VAS) questionnaire, Vacuum-formed retainer (VFR) technique, 3-D printed acrylic resin stent (3DS) technique, Flowable resin composite stent (FRC) technique, Photographs of the patient's palate, Measuring graft dimensions, Chairside Polymer Stent
- Other
- Lead sponsor
- Virginia Commonwealth University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 56 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Richmond, Virginia
- Conditions
- Short Bowel Syndrome, Malabsorption, Malnutrition
- Interventions
- HPN Group Clinic Appointments using Mobile Devices (experimental), Mobile Device Access (placebo)
- Behavioral
- Lead sponsor
- University of Kansas Medical Center
- Other
- Eligibility
- 13 Years and older
- Enrollment
- 121 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 1
- States / cities
- Kansas City, Kansas
- Conditions
- Acute Myocardial Infarction
- Interventions
- LCZ696 (sacubitril/valsartan), Ramipril, Placebo of LCZ696, Placebo of ramipril, Valsartan, Placebo of valsartan
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 5,669 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2021
- U.S. locations
- 81
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Gilbert, Arizona + 74 more
- Conditions
- Prevention of Meningococcal Disease
- Interventions
- MenACWY-CRM conjugate vaccine, adjuvanted, MenACWY-CRM conjugate vaccine, unadjuvanted, MenACWY polysaccharide vaccine
- Biological
- Lead sponsor
- Novartis Vaccines
- Industry
- Eligibility
- 11 Years to 17 Years
- Enrollment
- 524 participants
- Timeline
- 2004 – 2006
- U.S. locations
- 3
- States / cities
- Rochester, Minnesota • Pittsburgh, Pennsylvania • Seattle, Washington
- Conditions
- Postherpetic Neuralgia
- Interventions
- pregabalin, pregabalin/PF-00489791, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 72 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 39
- States / cities
- Huntsville, Alabama • Tallassee, Alabama • Chandler, Arizona + 29 more
- Conditions
- Breast Cancer
- Interventions
- Video and Booklet, Factsheet
- Behavioral
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 157 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2019
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Hypervascular Tumors
- Interventions
- Instylla HES, TAE or cTACE
- Device · Other
- Lead sponsor
- Instylla, Inc.
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 12
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Irvine, California + 9 more
- Conditions
- Vulvar and Vaginal Atrophy
- Interventions
- Estradiol Vaginal Tablets 10 mcg (Glenmark), Vagifem® (Estradiol Vaginal Tablets) 10 mcg (Novo Nordisk), Placebo of Estradiol Vaginal Tablets 10 mcg (Glenmark)
- Drug
- Lead sponsor
- Glenmark Pharmaceuticals Ltd. India
- Industry
- Eligibility
- 30 Years to 75 Years · Female only
- Enrollment
- 522 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016
- U.S. locations
- 1
- States / cities
- Mahwah, New Jersey
- Conditions
- Vulvar Intraepithelial Neoplasia (VIN)
- Interventions
- Sonopet Ultrasonic Aspirator, CO2 Laser Ablation
- Device
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 18 Years to 89 Years · Female only
- Enrollment
- 47 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2023
- U.S. locations
- 2
- States / cities
- Aurora, Colorado • Norman, Oklahoma
- Conditions
- Vascular Closure, Pacemaker Implantation, Leadless Pacemaker
- Interventions
- percutaneous suture mediated closure, Figure of Eight Suture
- Device
- Lead sponsor
- University of Massachusetts, Worcester
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Worcester, Massachusetts
- Conditions
- Aphasia, Acquired
- Interventions
- Conversation Treatment for Aphasia
- Behavioral
- Lead sponsor
- Boston University Charles River Campus
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 162 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 3
- States / cities
- Boston, Massachusetts • Maywood, New Jersey • Philadelphia, Pennsylvania
- Conditions
- Tachyarrhythmias, Atrial Fibrillation
- Interventions
- OptiSense Lead, Tendril Lead
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 2
- States / cities
- Akron, Ohio • Columbus, Ohio
- Conditions
- Anemia
- Interventions
- Lenalidomide, Placebo
- Drug · Other
- Lead sponsor
- Celgene
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 239 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2018
- U.S. locations
- 7
- States / cities
- Los Angeles, California • Centralia, Illinois • Lebanon, New Hampshire + 4 more
- Conditions
- Generalized Anxiety Disorder
- Interventions
- SEP-363856, Placebo
- Drug
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 384 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 21
- States / cities
- Phoenix, Arizona • Los Angeles, California • Redlands, California + 18 more
- Conditions
- Congenital Adrenal Hyperplasia
- Interventions
- Chronocort, Cortef, Placebo
- Drug · Other
- Lead sponsor
- Neurocrine UK Limited
- Industry
- Eligibility
- 16 Years and older
- Enrollment
- 55 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 11
- States / cities
- Los Angeles, California • Orange, California • Jacksonville, Florida + 8 more
- Conditions
- Clostridia Difficile Colitis, Clostridium; Sepsis
- Interventions
- Bezlotoxumab, Normal Saline
- Biological · Other
- Lead sponsor
- Ohio State University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Anxiety Sensitivity
- Interventions
- Standard exposure, Enhanced exposure, Intensive exposure, Expressive writing
- Behavioral
- Lead sponsor
- University of Wyoming
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 1
- States / cities
- Laramie, Wyoming
- Conditions
- Crohn's Disease
- Interventions
- Not listed
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Interstitial Cystitis, Painful Bladder Syndrome
- Interventions
- 2% sodium chondroitin sulfate, Placebo
- Drug
- Lead sponsor
- Watson Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 98 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 20
- States / cities
- Boulder, Colorado • Denver, Colorado • Farmington, Connecticut + 17 more